Nano-X Imaging Ltd.

As of March 31, 2022, Nano-X Imaging Ltd. is considered risky and overvalued due to negative performance metrics, including a non-applicable P/E ratio, an EV to EBITDA of -6.41, a ROCE of -48.61%, and a year-to-date stock return of -31.25% compared to the S&P 500's 2.44%.

As of June 2, 2025, the trend is mildly bearish, indicated by daily moving averages and Bollinger Bands, while weekly MACD and KST show mild bullish signals, resulting in a cautious outlook.

Nano-X Imaging Ltd. is an Israel-based company that develops a digital X-ray source aimed at reducing imaging system costs. As of March 2025, it reported net sales of $3 million and a net loss of $13 million, with a market cap of $322.64 million.

As of Jun 18, Nano-X Imaging Ltd. has a market capitalization of 322.64 million, with net sales of 11.55 million and a net profit loss of 54.52 million over the latest four quarters. The company's shareholder's funds were 189.12 million, and total assets amounted to 210.00 million.